| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.56B | -59.4% |
| Cost of Revenue | $693.7M | -69.0% |
| Gross Profit | $869.4M | -46.1% |
| R&D Expense | $60.8M | +23.9% |
| SG&A Expense | $772.9M | -41.9% |
| Operating Income | -$71.2M | -127.7% |
| Interest Expense | $24.1M | -66.9% |
| Pre-tax Income | -$2.1M | -101.3% |
| Income Tax | $36.1M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $24.3M | -96.6% |
| Accounts Receivable | $267.4M | -58.1% |
| Inventory | $426.6M | -45.0% |
| Current Assets | $795.0M | -65.5% |
| Total Assets | $4.27B | -49.8% |
| Current Liabilities | $565.2M | -44.8% |
| Long-term Debt | $259.3M | -87.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$55.9M | -115.7% |
| Capital Expenditures | $105.5M | +1.2% |
| Investing Cash Flow | -$176.4M | +45.0% |
| Financing Cash Flow | -$465.1M | -179.5% |
| Free Cash Flow | -$161.3M | -164.0% |
| -45.8% |
| Net Income | -$13.3M | -118.5% |
| EPS (Basic) | -$0.25 | -153.2% |
| EPS (Diluted) | -$0.25 | -154.3% |
| Total Liabilities |
| $823.4M |
| -78.6% |
| Stockholders' Equity | $3.45B | -25.3% |